Unicycive and Alarum: Pioneering New Innovations in Kidney Disease Treatment and Digital Security

Save
2 years ago
4
Unicycive Therapeutics Biotechnology company Kidney diseases Oxylanthanum carbonate (OLC) Hyperphosphatemia Chronic kidney disease Dialysis UNI-494 Patent-protected New chemical entity Late preclinical development

This week’s episode of the RedChip Money Report includes interviews with senior executives from Unicycive Therapeutics (NASDAQ: UNCY) and Alarum (NASDAQ: ALAR). Visit RedChip.com to learn more.

Loading comments...